微封装亚洲 (Centella asiatica) 增强巧克力麦牛奶饮料:配方,多含量和消费者接受度
Roselle Samaratunga1, Kevin Kantono1, Rothman Kam1
1Centre for Future Foods, Auckland University of Technology, Auckland, New Zealand.
Journal of food science
|August 14, 2024
概括
微封装的亚洲 (Centella asiatica) 可以增强巧克力麦奶中的多含量. 最佳水平 (高达4%) 提高了消费者接受度,而较高度可能会对味道和质感产生负面影响.
科学领域:
- 食品科学 食品科学 食品科学
- 营养保健品 营养保健品
- 植物化学 植物化学
背景情况:
- 亚洲 (CA) 含有具有潜在健康益处的生物活性化合物.
- 微封装是一种保护敏感生物活性化合物的技术,并改善其纳入食品矩阵的技术.
- 巧克力麦牛奶是功能成分强化的热门饮料基础.
研究的目的:
- 为了微封装 Centella asiatica (CA) 的生物活性成分.
- 为了配制一种新的巧克力麦牛奶饮料,增添了微封装的CA.
- 评估功能性饮料的多含量和消费者接受度.
主要方法:
- 用马尔托德克斯特林和阿拉伯口香糖微封装CA提取物,然后冷干燥.
- 微封装的CA被纳入各种度的巧克力麦奶中.
- 通过液态染色体质谱分析聚醇含量;通过消费者接受和检查所有适用的测试评估感觉性质.
主要成果:
- 增强巧克力麦奶含有14种多,包括亚洲酸和亚洲化物作为主要化合物.
- 增加微封装的CA度增加了饮料中的多含量.
- 含有2%和4%微封装CA的饮料很受欢迎,但较高度导致感官属性不那么可接受 (草,苦,土).
结论:
- 微封装的CA显示出作为巧克力麦奶中的功能成分的潜力.
- 该研究确定了微封装CA添加剂的最佳度,以保持消费者接受度.
- 有效的微封装保存了CA的生物活性多,为功能性食品产品开发提供了一个有前途的途径.
相关概念视频
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules
Bioequivalence in generic drugs, such as tablets and capsules, refers to their pharmaceutical equivalence to the brand-name counterparts. However, for therapeutic equivalence, manufacturers must also consider physical attributes like size, shape, and weight (FDA Guidance for Industry, December 2003). Discrepancies in these aspects could impact patient compliance and cause medication errors. For instance, swallowing difficulties, often experienced with larger tablets or capsules, can lead to...


